M&A Deal Summary |
|
|---|---|
| Date | 2023-05-15 |
| Target | Omega Laboratories |
| Sector | Life Science |
| Buyer(s) | Juno Pharma Canada |
| Sellers(s) | Sagent Pharmaceuticals |
| Deal Type | Divestiture |
SEARCH BY
Juno Pharma Canada is a specialty pharmaceutical company with a focus on injectable generic drugs sold through hospital channels. Juno Pharma Canada was founded in 2012 and is based in Montreal, Quebec.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Ohio M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 2006 |
| Sector | Life Science |
| Employees | 440 |
| Revenue | 318M USD (2015) |
Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products with a specific emphasis on injectables.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Ohio M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-10-01 |
Omega Laboratories
Mogadore, Ohio, United States Omega Laboratories is a pharmaceutical and specialty healthcare products company focused on manufacturing, innovation, quality, and rapid R&D development for the Canadian and global markets. The Hospital Division manufactures sterile vial format injectables, antiseptics, oncology injectables, and non-injectable pharmaceuticals for the Canadian and export markets and the Allergy and Phlebology Divisions provide specialized products and services for Canadian customers. Omega Laboratories was founded in 1958 and is based in Mogadore, Ohio. |
Buy | CA$95M |
